$21.98
0.75%
NYSE, Apr 21, 07:45 pm CET
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Pfizer Stock price

$22.14
-3.91 15.01% 1M
-7.13 24.36% 6M
-4.39 16.55% YTD
-3.28 12.90% 1Y
-29.70 57.29% 3Y
-12.82 36.68% 5Y
-11.05 33.30% 10Y
NYSE, Closing price Thu, Apr 17 2025
+0.10 0.45%
ISIN
US7170811035
Symbol
PFE
Sector
Industry

Key metrics

Market capitalization $125.57b
Enterprise Value $172.38b
P/E (TTM) P/E ratio 15.73
EV/FCF (TTM) EV/FCF 17.53
EV/Sales (TTM) EV/Sales 2.71
P/S ratio (TTM) P/S ratio 1.97
P/B ratio (TTM) P/B ratio 1.42
Dividend yield 7.63%
Last dividend (FY24) $1.69
Revenue growth (TTM) Revenue growth 8.77%
Revenue (TTM) Revenue $63.63b
EBIT (operating result TTM) EBIT $17.13b
Free Cash Flow (TTM) Free Cash Flow $9.84b
Cash position $20.48b
EPS (TTM) EPS $1.41
P/E forward 10.53
P/S forward 2.00
EV/Sales forward 2.74
Short interest 1.72%
Show more

Is Pfizer a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,780 stocks worldwide.

Pfizer Stock Analysis

Unlock Scores for Free

Analyst Opinions

23 Analysts have issued a Pfizer forecast:

8x Buy
35%
14x Hold
61%
1x Sell
4%

Analyst Opinions

23 Analysts have issued a Pfizer forecast:

Buy
35%
Hold
61%
Sell
4%

Financial data from Pfizer

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
63,627 63,627
9% 9%
100%
- Direct Costs 21,147 21,147
29% 29%
33%
42,480 42,480
48% 48%
67%
- Selling and Administrative Expenses 7,598 7,598
7% 7%
12%
- Research and Development Expense 10,738 10,738
2% 2%
17%
24,144 24,144
144% 144%
38%
- Depreciation and Amortization 7,013 7,013
11% 11%
11%
EBIT (Operating Income) EBIT 17,131 17,131
376% 376%
27%
Net Profit 8,020 8,020
276% 276%
13%

In millions USD.

Don't miss a Thing! We will send you all news about Pfizer directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pfizer Stock News

Neutral
24/7 Wall Street
about 3 hours ago
2025 hasn't been kind to investors amid rising concerns about a recession and tariffs.
Positive
FXEmpire
about 5 hours ago
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
Positive
Seeking Alpha
about 10 hours ago
Despite its historical underperformance and declining dividend growth trajectory, Pfizer's 7.63% dividend yield is attractive, making it a compelling income stock candidate. CEO Bourla's strategic focus on R&D, cost-cutting, and new revenue streams from acquisitions aims to mitigate upcoming revenue losses and drive future growth. Despite current challenges, Pfizer's robust cash flow, cost-savi...
More Pfizer News

Company Profile

Pfizer Inc. engages in the discovery, development, and manufacture of healthcare products specializes in medicines, vaccine, and consumer healthcare. It operates through the Pfizer Innovative Health (IH) and Pfizer Essential Health (EH) segments. The IH segment focuses on the development and commercializing medicines and vaccines for internal medicine, oncology, inflammation and immunology, rate disease, and consumer healthcare. The EH segment is involved in development and supply of branded generics, generic sterile injectable products, biosimilars, and select branded products including anti-infectives. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Head office United States
CEO Albert Bourla
Employees 81,000
Founded 1849
Website www.pfizer.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today